CB
Curon Biopharma specializes in developing targeted biopharmaceuticals that utilize monoclonal antibodies to treat autoimmune diseases. The company addresses the need for more effective therapies by enhancing patient outcomes through precision medicine tailored to individual immune responses.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Curon Biopharma specializes in developing targeted biopharmaceuticals that utilize monoclonal antibodies to treat autoimmune diseases. The company addresses the need for more effective therapies by enhancing patient outcomes through precision medicine tailored to individual immune responses.